Scientists Used AI to Create 16 New Viruses
The use of AI systems to create viruses opens up new possibilities for combating bacterial resistance. It also raises concerns about the pace at which technology is outstripping regulation.
In a groundbreaking study, scientists at Stanford University and the Arc Institute have utilized artificial intelligence (AI) to craft 16 entirely novel viruses. This innovative breakthrough represents a significant leap forward in the realm of molecular biomedicine and presents a potential solution to the ever-growing issue of bacterial resistance.
Traditionally, the creation of viral genomes has been limited to replicating known pathogens or variants, but this research introduces an entirely new approach. By leveraging AI models, namely Evo 1 and Evo 2, the scientists were able to generate unique genomes based on the extensive genetic sequences found in nature. These AI-driven viruses were designed to infect bacteria, specifically the bacterium Escherichia coli (E. coli), serving as an ideal test subject for the researchers.
The experiment involved synthesizing the 300 most promising AI-generated genomes, which were then introduced into E. coli bacteria to determine their functionality. Out of the 300 synthesized genomes, a mere 16 managed to create fully functional bacteriophages, exhibiting new sequences, genes, regulatory elements, and varied genome sizes.
Not only did these AI-generated viruses show potential as therapeutic agents, but they also demonstrated remarkable efficacy in combating antibiotic-resistant bacteria. In a test involving both AI-generated and naturally occurring phages, the former were able to swiftly overcome bacterial resistance and establish infection. This discovery opens up new avenues for the development of AI-generated phage therapies, which could evolve alongside rapidly evolving bacterial pathogens.
However, the implications of AI-generated viruses extend beyond their potential medical benefits. The creation of these viruses also raises concerns about their possible misuse, as malicious actors could exploit this technology to develop new diseases, highly toxic substances, or even pandemics. Moritz Hanke, a researcher at the Johns Hopkins Center for Health Security, highlights the urgent need for regulatory frameworks capable of keeping pace with scientific advancements.
As the gap between scientific progress and regulatory oversight widens, the potential risks associated with AI-generated viruses become increasingly concerning. The study, published in the journal Science, not only showcases the power of AI in the field of biotechnology but also sparks a vital conversation about the ethical considerations and safeguards necessary to prevent potential misuse of this groundbreaking technology.
Written by urgent.news from Wired Science's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
